Christina Dueno
Psychiatric/Mental Health · Moraine, OHNPI 1568813947
Payments from drug & device makers
Across 195 payments — averaging $26.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$1K
- Johnson & Johnson$713
- Axsome Therapeutics, Inc.$639
- Sunovion Pharmaceuticals Inc.$510
- Alkermes, Inc.$451
- Otsuka America Pharmaceutical, Inc.$333
- plus $1K from 15 others
What the payments were for
- Consulting fees$1,17323%
- Food & beverage$3,90677%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$1,551
- INVEGA SUSTENNA$1,173
- INVEGA TRINZA$102
How this compares
$5,079 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 317 | $508,263 |
| Invega SustennaPaliperidone Palmitate | 21 | $69,207 |
| CaplytaLumateperone Tosylate | 27 | $44,737 |
| AuvelityDextromethorphan Hbr/Bupropion | 24 | $21,108 |
| QuviviqDaridorexant Hcl | 23 | $11,257 |
| Lurasidone Hcl | 24 | $9,736 |
| TrintellixVortioxetine Hydrobromide | 15 | $9,098 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 27 | $2,631 |
| Aripiprazole | 12 | $2,329 |
| Duloxetine Hcl | 44 | $1,167 |
| Clozapine | 18 | $1,132 |
| Divalproex Sodium ErDivalproex Sodium | 28 | $1,052 |
| Memantine Hcl | 18 | $1,041 |
| Buspirone Hcl | 74 | $975 |
| Prazosin Hcl | 32 | $939 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato, Invega Sustenna | $713 | $577,470338 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $132 | $44,73727 claims |
| Axsome Therapeutics, Inc.Auvelity | $639 | $21,10824 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $14 | $11,25723 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $142 | $9,09815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Moraine
- Tamara ThornMoraine$89K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.